
Sports Medicine
Assessment of 2-year outcome between calcium phosphate-hybridized vs untreated STG autograft in ACLR
J Orthop Surg Res. 2018 Dec 29;13(1):327. doi: 10.1186/s13018-018-1045-190 patients scheduled for anterior cruciate ligament reconstruction with a hamstring autograft were randomized to either have the ends of the graft treated with calcium chloride and sodium phosphate solutions for calcium phosphate hybridization (CaP group), or to no treatment of the graft. Patients were assessed on CT scans for increase in cross-sectional area of the femoral and tibial bone tunnels to measure bone tunnel enlargement, as well as for the incidence of rerupture, objective and subjective knee laxity measures, and knee function scores. Follow-up was performed at 1 and 2 years postoperatively. The only significant difference observed between groups was in the increase in cross-sectional area of the femoral tunnel after 1 year, which was lower in the CaP group; the difference between groups at 2 years was not significant. In addition, no significant differences between groups were observed in tibial tunnel enlargement, rerupture rate, KT-1000 arthrometer results, pivot-shift test result, International Knee Documentation Committee grading, Lysholm score, or Tegner activity scale grading.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.